Hebrew University launches multidisciplinary center for cannabinoid research.
The Hebrew University of Jerusalem recently announced the launch of a Multidisciplinary Center on Cannabinoid Research. The new Center will serve as one of the world’s leading institutes for conducting and coordinating research about cannabinoids, endocannabinoids and medical cannabis. In addition, it will promote collaboration and disseminate information.
Staffed by some of the world’s leading scientists and medical doctors from the Hebrew University and its affiliated Hadassah Medical Center, the Multidisciplinary Center is already supporting exciting new research.
In February 2017, the Center awarded funding to three research projects: One on the effects of CBD on traumatic brain injury; another on the anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists; and a third on the effect of a Cannabis extract on acute radicular pain and on analgesics.
Hebrew University Multidisciplinary Center on Cannabinoid Research Director Dr. Joseph (Yossi) Tam said, "The establishment in Israel of the Multidisciplinary Center on Cannabinoid Research is of great relevance at this time since both academic institutions and pharmaceutical companies worldwide are channeling enormous efforts to basic and clinical research in this field.
"We feel incredibly fortunate to team up with a vast number of scientists working together on this expanding field of medicine with the significant potential to discover new therapies based on cannabinoids."
Dr. Tam also serves as Obesity and Metabolism Laboratory Head for Hebrew University's Drug and Research Institute.
Until very recently, the cannabis plant and its extracts (popularly called marijuana, hashish, weed, grass, and so on) were mostly frowned upon as purely recreational drugs. However, over the last 50 years, Prof. Raphael Mechoulam at the Hebrew University has spearheaded a new scientific era of Cannabis research.
Prof. Mechoulam with his colleagues isolated the active constituent of the cannabis plant, tetrahydrocannabinol, elucidated its structure and synthesized it. Later he identified the endogenous cannabinoids (formed in the mammalian body) and thus pioneered the field of cannabinoid research.
"It has been shown that modulating endocannabinoid activity has therapeutic potential in a large number of human diseases, hence research on cannabinoids may lead to very significant advances, not only in basic science but also in therapeutics.
"Our Multidisciplinary Center addresses many aspects in this promising area, such as cancer, head injury, addiction, bone formation, obesity and others," Mechoulam said.
Mechoulam is the head of the Academic Committee of the Multidisciplinary Center, as well as the university's Lionel Jacobson Professor Emeritus of Medicinal Chemistry.
The Center’s teams of highly qualified researchers comprise heads of labs and research groups ranging through nano-medicine and nano delivery systems, tumor micro-environment, neurobiology, pain relief and plasticity, molecular modeling & drug design, immuno-pharmacology, free radicals, and stress and plant pathogen interactions.
The Center’s informational resources include a world calendar of cannabinoids, featuring information about major upcoming events in the field of cannabinoid research. Its research will focus on cancer, pain, inflammation and stress management, immunity, metabolism, drug delivery and nanotechnology, pharmaceutical chemistry, neuroscience, and plant science and genetics.
Along with integrating the research activities of multiple Hebrew University research laboratories into interdisciplinary networks, the Center, will also foster collaborations between its participating laboratories and other well-established research groups around the globe.
http://www.israelnationalnews.com/News/News.aspx/227801
The Hebrew University of Jerusalem recently announced the launch of a Multidisciplinary Center on Cannabinoid Research. The new Center will serve as one of the world’s leading institutes for conducting and coordinating research about cannabinoids, endocannabinoids and medical cannabis. In addition, it will promote collaboration and disseminate information.
Staffed by some of the world’s leading scientists and medical doctors from the Hebrew University and its affiliated Hadassah Medical Center, the Multidisciplinary Center is already supporting exciting new research.
In February 2017, the Center awarded funding to three research projects: One on the effects of CBD on traumatic brain injury; another on the anti-angiogenic and anti-cancer activity of cannabinoid receptor 2 (CB2) agonists; and a third on the effect of a Cannabis extract on acute radicular pain and on analgesics.
Hebrew University Multidisciplinary Center on Cannabinoid Research Director Dr. Joseph (Yossi) Tam said, "The establishment in Israel of the Multidisciplinary Center on Cannabinoid Research is of great relevance at this time since both academic institutions and pharmaceutical companies worldwide are channeling enormous efforts to basic and clinical research in this field.
"We feel incredibly fortunate to team up with a vast number of scientists working together on this expanding field of medicine with the significant potential to discover new therapies based on cannabinoids."
Dr. Tam also serves as Obesity and Metabolism Laboratory Head for Hebrew University's Drug and Research Institute.
Until very recently, the cannabis plant and its extracts (popularly called marijuana, hashish, weed, grass, and so on) were mostly frowned upon as purely recreational drugs. However, over the last 50 years, Prof. Raphael Mechoulam at the Hebrew University has spearheaded a new scientific era of Cannabis research.
Prof. Mechoulam with his colleagues isolated the active constituent of the cannabis plant, tetrahydrocannabinol, elucidated its structure and synthesized it. Later he identified the endogenous cannabinoids (formed in the mammalian body) and thus pioneered the field of cannabinoid research.
"It has been shown that modulating endocannabinoid activity has therapeutic potential in a large number of human diseases, hence research on cannabinoids may lead to very significant advances, not only in basic science but also in therapeutics.
"Our Multidisciplinary Center addresses many aspects in this promising area, such as cancer, head injury, addiction, bone formation, obesity and others," Mechoulam said.
Mechoulam is the head of the Academic Committee of the Multidisciplinary Center, as well as the university's Lionel Jacobson Professor Emeritus of Medicinal Chemistry.
The Center’s teams of highly qualified researchers comprise heads of labs and research groups ranging through nano-medicine and nano delivery systems, tumor micro-environment, neurobiology, pain relief and plasticity, molecular modeling & drug design, immuno-pharmacology, free radicals, and stress and plant pathogen interactions.
The Center’s informational resources include a world calendar of cannabinoids, featuring information about major upcoming events in the field of cannabinoid research. Its research will focus on cancer, pain, inflammation and stress management, immunity, metabolism, drug delivery and nanotechnology, pharmaceutical chemistry, neuroscience, and plant science and genetics.
Along with integrating the research activities of multiple Hebrew University research laboratories into interdisciplinary networks, the Center, will also foster collaborations between its participating laboratories and other well-established research groups around the globe.
http://www.israelnationalnews.com/News/News.aspx/227801
